About PSM
Nanoguardian Sponsors Partnership for Safe Medicines Interchange
NanoGuardian™, a division of NanoInk®, focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. NanoGuardian has established itself as a pioneer in brand protection with the introduction of its NanoEncryption™ technology, the only on-dose, brand protection technology that enables manufacturers to trace and authenticate each and every dose from plant to…
[...]Bejon Misra Moderating Panel at Interchange
Bejon Misra, Founder of The Partnership for Safe Medicines India, will be moderating the 1:45pm panel, “The Role of Patients and Healthcare Professionals,” at the Partnership for Safe Medicines Interchange on October 27, 2011.
Mr. Misra has been in the consumer empowerment policy advocacy and research for the last 27 years and is also the Managing Director & Trustee of the Consumer Online Foundation and Chairman of Cell for Consumer Education & Advocacy (CCEA) based in New Delhi, India.
“I am looking forward to the Interchange as it will enable me to further empower the consumers in developing countries to access safe medicines at the most affordable price in partnership with the global leaders,” said Mr. Misra.
Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.
Merck Sponsors the Interchange
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada.
Through its prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, it work with customers and operate in more than 140 countries to deliver innovative health solutions. It also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.
Alex Dahl to Speak on Panel at The Partnership for Safe Medicines Interchange 2011
Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.
Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.
Partnership for Safe Medicines Opposes Legislation to Undermine Drug Safety Enforcements
Public Health Group Urges Senators to Prevent Influx of Counterfeit Medicines and Ensure Patient Safety by Opposing Vitter Importation Amendment Washington, D.C. (October 19, 2011) – Legislation that would prohibit the US Food and Drug Administration (FDA) from stopping the importation of potentially unsafe medicines, including those sold over the Internet, would raise the risk…
[...]Teva Pharmaceutical Industries Sponsors Partnership for Safe Medicines Interchange 2011
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world’s largest generic drug maker, with a global product portfolio of more than…
[...]Partnership for Safe Medicines Executive Director Speaks at Brazil Counterfeit Drug Forum
Washington, D.C. (October 17, 2011) – Addressing the growing public health crisis posed by counterfeit medicines in Brazil requires the coordinated effort of all stakeholders across the country, said Partnership for Safe Medicines Executive Director Scott LaGanga during a forum today in Rio de Janeiro on counterfeit medicines hosted by Interfarma and Brazilian newspaper O…
[...]Amgen Sponsors the Partnership for Safe Medicines Interchange
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in…
[...]Xuanhao Chan To Speak On Panel at Interchange
Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.
Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.
Lilly, Sponsor of the Partnership for Safe Medicines Interchange 2011
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Learn more about…
[...]